- Appointment shows Permira’s strong commitment to further growth in US Healthcare sector
- Strengthens Permira’s global expertise in outsourced pharma services
New York, 04 January 2024 – Permira, the global private equity firm, today announced that Jon Maschmeyer has joined its New York office as a Partner to drive the firm’s US healthcare sector efforts.
With over 20 years of experience in healthcare investing, Jon brings a wealth of knowledge and a proven track record to Permira, including most recently serving as Senior Partner and Co-Head of Healthcare at The Vistria Group, where he focused primarily on sourcing and executing investments in pharmaceutical services. Prior to joining Vistria, he served as a Partner at Chicago Pacific Founders, a strategic healthcare investment fund focused exclusively on healthcare services, where he was instrumental in identifying and driving value for the firm’s first investments following its launch. He was previously a healthcare investor with Pritzker Group and RoundTable Healthcare Partners. Earlier in his career, Jon held investment banking roles at Merrill Lynch and Greenhill.
At Permira, Jon will play a pivotal role in both identifying new strategic investment opportunities and working closely with the firm’s portfolio companies to execute on their strategic growth drivers and generate value. Jon will bring a deeper focus on pharmaceutical services and the associated value chain while preserving and driving the team’s existing focus on medical and pharmaceutical products.
Silvia Oteri, Partner and Global Head of Healthcare at Permira, said: “As a team, we’ve known Jon for some time and are thrilled to welcome him to Permira. With two decades of healthcare investing under his belt, he brings extensive industry knowledge and an impressive network in the healthcare space. With Jon joining, we plan to build on our wider US healthcare team’s investment achievements of prior years as we partner with companies and management teams to drive long-term growth. We’re excited for what’s to come.”
Jon Maschmeyer, Partner at Permira, added: “Permira’s healthcare team has been one to watch for many years and I have long admired their focused and differentiated investment strategy as well as their partnership approach. As the sector adapts to innovation and digitization, it is a fascinating time to partner with successful entrepreneurs and management teams in the healthcare industry to embrace and leverage those changes and accelerate companies’ growth. I’m grateful to have the opportunity to join the team to advance the firm’s goal of improving the quality of healthcare provision globally.”
Permira is one of the world’s most active investors in the healthcare sector, having deployed over €4 billion to partner with approximately 20 companies globally. Current investments from the Permira funds in the sector include Ergomed, Kedrion Biopharma, Neuraxpharm, Cambrex, Quotient Sciences and I-Med.
